 BOSTON, Sept. 06, 2022 GLOBE NEWSWIRE -- Inozyme Pharma, Inc. Nasdaq: INZY, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced Axel Bolte, MSc, MBA, the companys co-founder, president, and chief executive officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference. The prerecorded presentation will become available on-demand on Monday, September 12, 2022, at 7:00 AM ET. 